Sodium iodide Na131I POLATOM, capsules for therapeutic use 131

Radionuclidic purity: 

≥ 99.9%

Radiochemical purity: 

≥ 95%

Calibration:  7 days
Expiration:  21 days from the production date.
Storage:  Store below 25°C.
Pharmaceutical form: 

Hard capsules.

Active substance: 

Sodium Iodide (Na131I) [37 – 5500 MBq]

Excipients:  Sodium carbonate
Sodium bicarbonate
Disodium hydrogen phosphate dihydrate
Sodium thiosulphate pentahydrate
Hard gelatin capsule (bovine gelatin, dyes: titanium dioxide, quinoline yellow, indigotine, erythrosine, iron oxides)
Package:  Gelatin capsules for therapeutic use are provided in the two types of direct packaging:
– the polyethylene vial closed with a polyethylene stopper containing isolated iodide absorber and placed in a shielding lead container. The package contains a single capsule. Each box is accompanied by a separate polypropylene applicator (TYPE A) with polyethylene plug for capsule administration and certificate of radiopharmaceutical activity or
– the polypropylene vial closed with a polypropylene stopper containing isolated iodide absorber and placed in a shielding lead container. The package contains a single capsule. Each box is accompanied by a separate polypropylene applicator (TYPE B) for capsule administration and certificate of radiopharmaceutical activity.
Indications:  The preparation is used in the treatment of: thyroid nodular goitre, hyperthyroidism in the Graves-Basedow’s disease, autonomic nodule and the Plummer‘s disease. It is used for  the thyroid residue ablation after surgery of differentiated thyroid tumours and in the treatment of metastases of iodine-accumulating  differentiated thyroid cancers.
Załączniki:  Sodium iodide Na131I POLATOM, capsules for therapeutic use

Files Sodium iodide Na131I POLATOM, capsules for therapeutic use